Purdue Pharma’s Payments to Sacklers Soared Amid Opioid Crisis

A new audit finds that the family directed $10.7 billion from the drugmaker to family-controlled trusts and holding companies, as legal pressure tightened around Purdue.

from NYT > Health https://ift.tt/36GmEUP
via health&fitness